Ex-Trump Health Official Backs Medicare Coverage for Wegovy, Opposes Price Negotiation
2025-01-17
STAT
A former Trump administration health official, Joe Grogan, has expressed support for the Biden proposal to have Medicare and Medicaid cover GLP-1 weight-loss drugs like Wegovy. However, Grogan disagrees with the idea of subjecting Wegovy to price controls, citing concerns over the impact on pharmaceutical innovation and access to obesity treatment. This debate highlights the ongoing discussion around healthcare policy, Medicare coverage, and prescription drug pricing. With the rising prevalence of obesity, the coverage of weight-loss medications has become a pressing issue. Popular keywords like 'healthcare reform' and 'prescription drug costs' are at the forefront of this conversation.
